ZA200204983B - Substituted homopiperidinyl benzimidazole analogues as fundic relaxants. - Google Patents

Substituted homopiperidinyl benzimidazole analogues as fundic relaxants. Download PDF

Info

Publication number
ZA200204983B
ZA200204983B ZA200204983A ZA200204983A ZA200204983B ZA 200204983 B ZA200204983 B ZA 200204983B ZA 200204983 A ZA200204983 A ZA 200204983A ZA 200204983 A ZA200204983 A ZA 200204983A ZA 200204983 B ZA200204983 B ZA 200204983B
Authority
ZA
South Africa
Prior art keywords
formula
compound
hydroxy
galkyl
hydrogen
Prior art date
Application number
ZA200204983A
Other languages
English (en)
Inventor
Frans Eduard Janssen
Francois Maria Sommen
Jerome Emile George Guillemont
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZA200204983B publication Critical patent/ZA200204983B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cosmetics (AREA)
ZA200204983A 1999-12-21 2002-06-20 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants. ZA200204983B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99204441 1999-12-21

Publications (1)

Publication Number Publication Date
ZA200204983B true ZA200204983B (en) 2003-09-22

Family

ID=8241040

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200204983A ZA200204983B (en) 1999-12-21 2002-06-20 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants.

Country Status (33)

Country Link
US (1) US7304052B2 (cs)
EP (1) EP1250337B1 (cs)
JP (1) JP4852210B2 (cs)
KR (1) KR100715351B1 (cs)
CN (1) CN100343251C (cs)
AT (1) ATE416174T1 (cs)
AU (1) AU781144B2 (cs)
BG (1) BG65784B1 (cs)
BR (1) BRPI0016638B8 (cs)
CA (1) CA2393158C (cs)
CY (1) CY1108844T1 (cs)
CZ (1) CZ299803B6 (cs)
DE (1) DE60041001D1 (cs)
DK (1) DK1250337T3 (cs)
EA (1) EA005851B1 (cs)
EE (1) EE05182B1 (cs)
ES (1) ES2317856T3 (cs)
HK (1) HK1053109B (cs)
HR (1) HRP20020518B1 (cs)
HU (1) HU229929B1 (cs)
IL (2) IL150310A0 (cs)
MX (1) MXPA02006346A (cs)
MY (1) MY127758A (cs)
NO (1) NO322362B1 (cs)
NZ (1) NZ518816A (cs)
PL (1) PL199678B1 (cs)
PT (1) PT1250337E (cs)
SI (1) SI1250337T1 (cs)
SK (1) SK287113B6 (cs)
TW (1) TWI225488B (cs)
UA (1) UA73963C2 (cs)
WO (1) WO2001046189A1 (cs)
ZA (1) ZA200204983B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI225488B (en) 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus
US7160879B2 (en) 2002-01-10 2007-01-09 Neurogen Corporation Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1H-benzoimidazole analogues
JPWO2005080348A1 (ja) * 2004-02-19 2007-08-02 萬有製薬株式会社 新規スルホンアミド誘導体
PL2121683T3 (pl) * 2007-01-25 2012-01-31 Janssen Pharmaceutica Nv Pochodne 2-piperazyn-1-ylo-3H-imidazo[4,5-b]pirydyny
MX2012015292A (es) 2010-06-24 2013-05-30 Gilead Sciences Inc Pirazolo[1, 5]pirimidinas en la forma de agentes antivirales.
EP2643304A2 (en) * 2010-11-24 2013-10-02 Sequent Scientific Ltd. A process for preparation of albendazole
JP2014159375A (ja) * 2011-06-15 2014-09-04 Takeda Chem Ind Ltd アゼパン化合物
CA2858096C (en) 2011-12-22 2020-06-23 Gilead Sciences, Inc. Pyrazolo[1,5-a]pyrimidines as antiviral agents
PT2838900T (pt) 2012-04-17 2019-11-15 Gilead Sciences Inc Compostos e métodos para tratamento antiviral
WO2015091584A1 (en) * 2013-12-18 2015-06-25 F. Hoffmann-La Roche Ag Thiazolopyridine compounds, compositions and their use as tyk2 kinase inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2060197C3 (de) 1970-12-08 1979-02-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von 2-Aminobenzothiazol und dessen N-Alkylsubstitutionsprodukten
US4093726A (en) * 1976-12-02 1978-06-06 Abbott Laboratories N-(2-benzimidazolyl)-piperazines
ES8101067A1 (es) * 1978-08-25 1980-12-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona
JPS5879983A (ja) * 1981-11-06 1983-05-13 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
FR2528526A1 (fr) * 1982-06-09 1983-12-16 Sfr Sa Robinetterie Butee se fixant dans un alesage d'un dispositif
DE3224512A1 (de) * 1982-07-01 1984-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazolderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
DE3634066A1 (de) * 1986-10-07 1988-04-21 Boehringer Mannheim Gmbh Neue 5-alkylbenzimidazole, verfahren zu ihrer herstellung sowie arzneimittel
JPH0260197A (ja) * 1988-08-26 1990-02-28 Nec Corp パッケージ構造
FR2674856B1 (fr) * 1991-04-05 1993-07-30 Esteve Labor Dr Nouveaux antihistaminiques non sedatifs, derives de benzimidazole, leur procede de preparation et leur utilisation en tant que medicaments.
IL101851A (en) * 1991-06-13 1996-05-14 Janssen Pharmaceutica Nv 10-(4-piperidinyl- and piperidinylidene)-imidazo [1,2-a] (pyrrolo thieno or furano) [2,3] azepine derivatives their preparation and pharmaceutical compositions containing them and certain novel intermediates therefor
DE4237656A1 (de) * 1992-06-13 1993-12-16 Merck Patent Gmbh Benzimidazolderivate
CA2138787A1 (en) * 1992-07-08 1994-01-20 Clifton Augustus Baile Alleviating stomach ulcers in swine
ES2048109B1 (es) * 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
CA2168016C (en) * 1994-05-31 2000-09-26 Akio Matsunaga Benzimidazole derivatives
FR2766822B1 (fr) * 1997-07-30 2001-02-23 Adir Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6150379A (en) * 1997-11-26 2000-11-21 Axys Pharmaceuticals, Inc. Compounds and compositions as anticoagulants
TWI225488B (en) 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues

Also Published As

Publication number Publication date
BG65784B1 (bg) 2009-11-30
CA2393158C (en) 2010-10-19
PT1250337E (pt) 2009-03-05
JP4852210B2 (ja) 2012-01-11
IL150310A0 (en) 2002-12-01
EE05182B1 (et) 2009-06-15
BR0016638A (pt) 2002-10-01
HK1053109B (zh) 2008-08-01
AU2167301A (en) 2001-07-03
HUP0203847A2 (hu) 2003-03-28
EA005851B1 (ru) 2005-06-30
NZ518816A (en) 2003-01-31
BG106749A (en) 2003-01-31
HK1053109A1 (zh) 2003-10-10
IL150310A (en) 2008-07-08
PL199678B1 (pl) 2008-10-31
BR0016638B1 (pt) 2013-02-05
SI1250337T1 (sl) 2009-04-30
HRP20020518B1 (en) 2009-02-28
BRPI0016638B8 (pt) 2017-04-25
NO322362B1 (no) 2006-09-25
KR20020062643A (ko) 2002-07-26
CZ20022055A3 (cs) 2003-06-18
SK287113B6 (sk) 2009-12-07
EA200200700A1 (ru) 2003-06-26
HU229929B1 (en) 2015-01-28
JP2003518118A (ja) 2003-06-03
HRP20020518A2 (en) 2004-08-31
ES2317856T3 (es) 2009-05-01
NO20022977D0 (no) 2002-06-20
TWI225488B (en) 2004-12-21
CZ299803B6 (cs) 2008-12-03
CY1108844T1 (el) 2014-07-02
EP1250337A1 (en) 2002-10-23
UA73963C2 (uk) 2005-10-17
HUP0203847A3 (en) 2004-07-28
AU781144B2 (en) 2005-05-05
SK8542002A3 (en) 2003-07-01
CA2393158A1 (en) 2001-06-28
US7304052B2 (en) 2007-12-04
EE200200326A (et) 2003-10-15
MY127758A (en) 2006-12-29
NO20022977L (no) 2002-08-08
WO2001046189A1 (en) 2001-06-28
US20030139393A1 (en) 2003-07-24
MXPA02006346A (es) 2002-12-13
KR100715351B1 (ko) 2007-05-08
DK1250337T3 (da) 2009-03-30
EP1250337B1 (en) 2008-12-03
CN1411460A (zh) 2003-04-16
PL355442A1 (en) 2004-04-19
DE60041001D1 (de) 2009-01-15
CN100343251C (zh) 2007-10-17
ATE416174T1 (de) 2008-12-15

Similar Documents

Publication Publication Date Title
RU2070884C1 (ru) Производные n-(4-пиперидинил)(дигидробензофуран или дигидро-2н-бензопиран)-карбоксиамида или их соли, или их стереоизомеры, способы их получения, промежуточные соединения для них, фармацевтическая композиция на основе производных n-(4-пиперидинил)(дигидробензофуран или дигидро-2н-бензопиран)карбоксиамида
JP2008534496A (ja) ＣＢ１’受容体リガンドとしての新規なテトラヒドロ−１Ｈ−ピリド［４，３−ｂ］インドール誘導体
BG63709B1 (bg) Гастрокинетични бициклени бензамиди на 3- или 4- заместени 4-(аминометил)-пиперидинови производни
GB2292143A (en) Pyrrolo-pyridine derivatives
WO2012003829A1 (en) Novel homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof
AU724401B2 (en) Novel N-substituted 4-((4'-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties
ZA200204983B (en) Substituted homopiperidinyl benzimidazole analogues as fundic relaxants.
CN1177847C (zh) 作为5－ht2a拮抗剂的噁唑烷酮类化合物
CN1097053C (zh) 1,2,3,4－四氢－苯并呋喃并[3,2,－c]吡啶衍生物，其制备方法和用途
CZ91897A3 (en) Derivatives of n-substituted piperidinyl bicyclic benzoates
JP5101639B2 (ja) アミド誘導体及びそれを含有する医薬組成物
JP2004277318A (ja) １−（１−置換カルボニル−４−ピペリジニルメチル）ピペリジン誘導体およびそれを含有する医薬組成物
JP2004277319A (ja) １−（４−ピペリジニルメチル）ピペリジニルアミド誘導体およびそれを含有する医薬組成物
JP2005082508A (ja) ２−アルコキシ−６−アミノ−５−ハロゲノ−ｎ−（１−置換−４−ピペリジニル）ピリジン−３−カルボキサミド誘導体およびそれを含有する医薬組成物
JP2004277320A (ja) １，４−ジ置換ピペリジン誘導体およびそれを含有する医薬組成物
CA1253156A (en) 2h-azeto¬2,1-a|-isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them
JP2000080081A (ja) １―〔（１―置換―４―ピペリジニル）メチル〕―４―ピペリジン誘導体及びそれを含有する医薬組成物
JP2011063586A (ja) アミド誘導体からなる医薬
IL124321A (en) Esters of the history of 3-hydroxy-piperidinemethanol, intermediates and process for their preparation and pharmaceutical preparations containing them
HK1262295A1 (en) 6,7-dihydro-5h-pyrazolo[5，1-b][1,3]oxazine-2-carboxamide compounds